PDE / ADE · OEL / OEB

Home→PDE/ADE · OEL/OEB Profiles → Ethanol→

Ethanol PDE report and OEL report profile

Project-specific health-based exposure limit and occupational toxicology assessment support. The agreed scope may include PDE/ADE derivation, OEL derivation and OEB/OHC banding, based on the exact substance form, available evidence and intended product or workplace context.

CAS Registry Number
64-17-5
Molecular formula
C2H6O
Molecular weight
46.0684 g/mol
Drug class
Alcoholtopical antiseptic and chemical neurolytic agent depending on concentration and route
Mechanism of action
At antiseptic concentrations, ethanol denatures proteins and disrupts microbial membranes. When injected for chemical neurolysis, concentrated ethanol extracts membrane lipids and causes axonal and Schwann-cell injury, interrupting nerve conduction.
Indications / reported uses
  • Skin antisepsis and disinfection in appropriately formulated topical products.
  • Chemical neurolysis of selected nerves or plexuses in specialist pain procedures for severe refractory pain; injection use is procedure-specific.

Sources: https://www.ncbi.nlm.nih.gov/books/NBK537360/ · https://pmc.ncbi.nlm.nih.gov/articles/PMC9671686/ · FDA product information

View request basketPrefer email? info@toxwriter.com
PDE / ADE derivationOEL derivationOEB / OHC banding
Assessment scope

PDE/ADE and OEL/OEB assessment

ToxWriter provides project-specific support for Ethanol PDE/ADE, OEL and OEB/OHC assessments. This combined profile covers the Ethanol Permitted Daily Exposure (PDE) report (the Ethanol PDE report); Acceptable Daily Exposure (ADE) is the corresponding health-based daily exposure terminology. It also covers the Ethanol Occupational Exposure Limit (OEL) report (the Ethanol OEL report). PDE/ADE derivation and workplace exposure assessment are distinct scientific outputs; a band is not a numerical OEL.

Assessment may cover

  • PDE/ADE derivation using relevant toxicological evidence, critical effects, a justified point of departure and adjustment factors.
  • OEL derivation considering relevant hazards, exposure route, duration and workplace conditions.
  • OEB/OHC banding where requested and supported by the evidence; an exposure band is not a numerical OEL.
  • Review of substance identity, evidence quality, uncertainty and data gaps.
PDE/ADE, OEL & OEB/OHC regulatory framework

The EMA HBEL guideline informs PDE/ADE assessments in relevant shared-facility contexts. ECHA and HSE sources address workplace exposure limits; NIOSH provides occupational exposure-banding guidance. The applicable framework depends on the assessment question and jurisdiction.